Abstract
During the early phase of the COVID-19 pandemic, many respiratory therapies were classified as aerosol-generating procedures (AGPs). This categorization resulted in a broad range of clinical concerns and a shortage of essential medical resources for some patients. In the past two years, many studies have assessed the transmission risk posed by various respiratory care procedures. These studies are discussed in this narrative review, with recommendations for mitigating transmission risk based on the current evidence.
Footnotes
- Correspondence to:
Jie Li, PhD, RRT, RRT-ACCS, RRT-NPS, FAARC. 600 S Paulina St, Suite 765, Chicago, IL, USA. E-mail: Jie_Li{at}rush.edu
- Received March 16, 2022.
- Accepted April 5, 2022.
- Copyright © 2022 by Daedalus Enterprises
A Narrative Review on Aerosol Generating Procedures and Virus Transmission
